Phase 1 Prostatic Neoplasms, Castration-Resistant trials recruiting now

All Prostatic Neoplasms, Castration-Resistant trials, every phase

Other phases for Prostatic Neoplasms, Castration-Resistant

Phase 1 Prostatic Neoplasms, Castration-Resistant trials

• 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
  NCT04868604 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 7 locations
• A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT07719361 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 10 locations
• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
  NCT04104776 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 160 locations
• Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
  NCT06190899 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 13 locations
• HTL0039732 in Participants With Advanced Solid Tumours
  NCT05944237 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
  NCT05743621 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location
• Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
  NCT06353386 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 77 locations

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.